Thibault Boutherin
Stock Analyst at Morgan Stanley
(3.09)
# 2,457
Out of 4,355 analysts
148
Total ratings
55.2%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 270.00 → kr 250.00 | $295.10 | -15.28% | 6 | May 7, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $117.82 | +14.58% | 11 | Apr 28, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Hold | CHF 155.00 → CHF 160.00 | $166.55 | -3.93% | 9 | Apr 27, 2026 | |
| NVS Novartis AG | Maintained: Buy | $143 → $170 | $150.17 | +13.21% | 3 | Mar 26, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €40.00 → €53.00 | $36.53 | +45.09% | 5 | Mar 11, 2026 | |
| BME: GRF Grifols, S.A. | Downgraded: Hold | €12.00 → €11.00 | $9.28 | +18.53% | 7 | Mar 10, 2026 | |
| NVO Novo Nordisk | Upgraded: Hold | $42 → $40 | $45.58 | -12.24% | 5 | Mar 3, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Hold | €130.00 → €135.00 | $130.85 | +3.17% | 5 | Dec 3, 2025 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 650.00 | $500.40 | +29.90% | 10 | Dec 3, 2025 | |
| ALVO Alvotech | Maintained: Buy | $14 → $10 | $3.36 | +197.62% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 50.00 | $65.60 | -23.78% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €300.00 | $245.10 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 | $178.10 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €715.00 | $720.80 | n/a | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,100p → 2,400p | $1,476.00 | n/a | 15 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $3.07 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €12.00 | $5.28 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 912p | $1,281.00 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €120.00 | $156.60 | n/a | 18 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 → $41 | $84.12 | n/a | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 4.00 → CHF 1.00 | $4.47 | n/a | 11 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | €0.87 → €105.00 | $244.16 | n/a | 12 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $7.85 | n/a | 4 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.50 → €11.00 | $11.38 | n/a | 5 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $35.32 | n/a | 2 | Oct 4, 2023 |
Novo Nordisk A/S
May 7, 2026
Maintained: Hold
Price Target: kr 270.00 → kr 250.00
Current: $295.10
Upside: -15.28%
Novartis AG
Apr 28, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $117.82
Upside: +14.58%
Galderma Group AG
Apr 27, 2026
Maintained: Hold
Price Target: CHF 155.00 → CHF 160.00
Current: $166.55
Upside: -3.93%
Novartis AG
Mar 26, 2026
Maintained: Buy
Price Target: $143 → $170
Current: $150.17
Upside: +13.21%
Bayer Aktiengesellschaft
Mar 11, 2026
Maintained: Buy
Price Target: €40.00 → €53.00
Current: $36.53
Upside: +45.09%
Grifols, S.A.
Mar 10, 2026
Downgraded: Hold
Price Target: €12.00 → €11.00
Current: $9.28
Upside: +18.53%
Novo Nordisk
Mar 3, 2026
Upgraded: Hold
Price Target: $42 → $40
Current: $45.58
Upside: -12.24%
Merck KGaA
Dec 3, 2025
Maintained: Hold
Price Target: €130.00 → €135.00
Current: $130.85
Upside: +3.17%
Lonza Group AG
Dec 3, 2025
Maintained: Buy
Price Target: CHF 650.00
Current: $500.40
Upside: +29.90%
Alvotech
Dec 3, 2025
Maintained: Buy
Price Target: $14 → $10
Current: $3.36
Upside: +197.62%
Dec 3, 2025
Maintained: Hold
Price Target: CHF 38.00 → CHF 50.00
Current: $65.60
Upside: -23.78%
Apr 22, 2025
Maintained: Buy
Price Target: €300.00
Current: $245.10
Upside: n/a
Apr 22, 2025
Maintained: Buy
Price Target: €250.00
Current: $178.10
Upside: n/a
Mar 5, 2025
Maintained: Buy
Price Target: €715.00
Current: $720.80
Upside: n/a
Feb 12, 2025
Maintained: Hold
Price Target: 2,100p → 2,400p
Current: $1,476.00
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: $14
Current: $3.07
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: €12.00
Current: $5.28
Upside: n/a
Jul 15, 2024
Maintained: Buy
Price Target: 912p
Current: $1,281.00
Upside: n/a
May 15, 2024
Maintained: Hold
Price Target: €120.00
Current: $156.60
Upside: n/a
May 8, 2024
Maintained: Hold
Price Target: $38 → $41
Current: $84.12
Upside: n/a
Apr 3, 2024
Maintained: Sell
Price Target: CHF 4.00 → CHF 1.00
Current: $4.47
Upside: n/a
Mar 25, 2024
Upgraded: Hold
Price Target: €0.87 → €105.00
Current: $244.16
Upside: n/a
Dec 29, 2023
Maintained: Hold
Price Target: $16
Current: $7.85
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: €11.50 → €11.00
Current: $11.38
Upside: n/a
Oct 4, 2023
Maintained: Hold
Price Target: $10
Current: $35.32
Upside: n/a